Essex Bio-Technology
Essex Bio Group is an investor and manufacturer of biopharmaceutical products.
Business Model:
Revenue: $115.1M
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Essex Bio-Technology Information
Geographic Data
Address: 168-200 Connaught Road Central
City: Hong Kong
State: other
Zip:
Country: HK
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects. A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company&s;s products are Beifuji, Beifushu and Beifuxin.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2018 | Shang Gong | Series A | 0 |
| 5/2018 | X-ZELL | Seed Round | 4M |
| 3/2018 | MeiraGTx | Series B | 5M |
| 7/2018 | Shang Gong | Series A | 0 |
| 5/2018 | X-ZELL | Seed Round | 0 |
| 3/2018 | MeiraGTx | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
